Avanos Medical Inc represents a strong set of values and a dedicated corporate philosophy. The company is committed to improving patients' lives through innovative medical solutions. Avanos prioritizes patient-centered care, ensuring their products and services meet the highest standards of quality and safety. The company values integrity, empathy, and collaboration, fostering a culture of trust and respect among its employees and stakeholders. Avanos is driven by a passion for advancing healthcare and delivering positive patient outcomes. Through continuous innovation and a focus on customer satisfaction, Avanos strives to be a leading provider of healthcare solutions worldwide.

Avanos Medical Inc is primarily present in various countries and regions worldwide. With a global presence, the company serves customers across North America, Europe, Asia Pacific, Latin America, and the Middle East. Its products and services have gained popularity in countries like the United States, Canada, Germany, France, Italy, United Kingdom, China, Japan, Australia, Brazil, Mexico, Saudi Arabia, and the United Arab Emirates. Avanos Medical Inc's extensive geographical reach highlights its commitment to delivering healthcare solutions internationally, making it a trusted and recognized name in the medical industry around the globe.

Avanos Medical Inc has achieved several significant milestones throughout its history. The company has successfully expanded its product portfolio, introduced innovative medical devices, and demonstrated consistent revenue growth. Avanos Medical Inc has successfully established a strong global presence, with a diverse customer base and strategic partnerships. Additionally, the company has received numerous accolades and recognitions for its contributions to the healthcare industry. Avanos Medical Inc continues to be a leader in the medical technology sector, driving advancements and delivering high-quality solutions to improve patient outcomes.

Avanos Medical Inc, formerly known as Halyard Health, is a leading medical device company that specializes in the development and manufacturing of innovative healthcare solutions. Established in 2014, Avanos has a rich history with roots tracing back to Kimberly-Clark Corporation. With a commitment to improving patient outcomes and enhancing healthcare standards, Avanos prides itself on delivering high-quality, evidence-based products and technologies. The company focuses on four key areas: surgical pain management, interventional pain management, chronic care solutions, and digestive health. Avanos strives to continually advance medical science and provide healthcare professionals with cutting-edge tools to improve patient care.

The main competitors of Avanos Medical Inc in the market include companies such as Medtronic, Johnson & Johnson, Becton Dickinson, and Boston Scientific. Avanos Medical Inc faces competition from these industry leaders in the medical device and healthcare sector. It engages in continuous research and development to stay competitive and maintain its market position against these formidable rivals.

Avanos Medical Inc operates primarily in the healthcare industry. As a global medical technology company, it focuses on developing and providing innovative solutions in the fields of medical devices and healthcare products. Avanos Medical Inc specializes in areas such as pain management, respiratory health, and surgical procedure support. With its commitment to advancing patient care, the company offers a wide range of products and services to cater to the needs of healthcare professionals and patients worldwide. Avanos Medical Inc's expertise lies in delivering effective and safe healthcare solutions for improved patient outcomes.

Avanos Medical Inc's business model focuses on providing innovative medical solutions to healthcare providers worldwide. As a global medical technology company, Avanos develops and manufactures a wide range of products, including surgical and anesthesia products, respiratory equipment, and pain management solutions. By leveraging its expertise and advanced technologies, Avanos aims to improve patient outcomes and enhance healthcare efficiency. The company continuously invests in research and development to develop groundbreaking solutions that address unmet medical needs. Avanos Medical Inc is committed to delivering high-quality products and services that positively impact patient care across various medical specialties.

De Avanos Medical K/W is 14,05.

De Avanos Medical KUV is 1,28.

De AlleAktien Kwaliteitsscore voor Avanos Medical is 1/10.

De verwachte Avanos Medical omzet is 709,31 mln. USD.

De verwachte Avanos Medical winst is 64,39 mln. USD.

Avanos Medical Inc is a leading company in the medical technology industry, specializing in innovative products for pain relief, wound care, and respiratory therapy. The company is headquartered in Alpharetta, Georgia, USA and employs over 4,000 employees worldwide. Avanos Medical is divided into three business segments: Interventional Specialties, Pain Management, and Wound Care. Interventional Specialties: In this business segment, Avanos Medical offers products used in minimally invasive procedures for pain relief. An example of this is soft tissue needles used for injecting pain medication directly into the affected tissue. Another example is catheters for pain relief that can be inserted directly into the spine or specific nerves. Pain Management: This business segment focuses on the development of products for pain relief and treatment. Avanos Medical offers products such as patch pumps for continuous pain therapy, enabling controlled and effective pain management. Another example is opioid-sparing technology, which combines medications to reduce the dosage of opioids and thus lower the risk of side effects. Wound Care: In the wound care business segment, Avanos Medical focuses on developing products that accelerate wound healing and facilitate the treatment of chronic wounds. For example, the company offers hydrocolloid dressings that create a moist wound environment, promoting faster healing. Another product is the Negative-Pressure Wound Therapy System (NPWT), which helps clean wounds and remove wound exudate to promote healing. Overall, Avanos Medical offers a wide range of products that contribute to pain relief, faster wound healing, and improved quality of life for patients. The company is committed to continuously expanding and improving its product offerings to meet the needs of patients and healthcare professionals. In addition to products, Avanos Medical also provides training and support for healthcare professionals to ensure proper and effective use of their products. The company has also formed partnerships with other medical companies to drive innovation and the development of new products. Overall, Avanos Medical's business model is focused on the development and distribution of high-quality medical products that improve the lives of patients. The company has established itself as a key player in the medical technology industry and is expected to continue expanding in the future.

Avanos Medical keert een dividend van 0 USD uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Avanos Medical of het bedrijf keert geen dividend uit.

De ISIN van Avanos Medical is US05350V1061.

Het WKN van Avanos Medical is A2JNRG.

De ticker van Avanos Medical is AVNS.

Binnen de laatste 12 maanden betaalde Avanos Medical een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal Avanos Medical naar verwachting een dividend van 0 USD betalen.

De dividendrendement van Avanos Medical is momenteel .

Avanos Medical betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

Avanos Medical betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 USD verwacht. Dit komt overeen met een dividendrendement van 0 %.

Avanos Medical wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Avanos Medical van 5-7-2024 ter hoogte van 0 USD te ontvangen, moest je het aandeel voor de ex-datum op 5-7-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 5-7-2024.

In het jaar 2023 heeft Avanos Medical 0 USD aan dividenden uitgekeerd.

De dividenden van Avanos Medical worden in USD uitgekeerd.